TheEdgeResearch
Home / Stocks / VYYRF

Voyageur Pharmaceuticals Ltd. (VYYRF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.07 ▲ +0.00%
Market Cap
$11.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.34
52-Wk Range
0.0033-0.24
CEO
Brent Willis
Country
CA
Currency
USD

Voyageur Pharmaceuticals Ltd. is dedicated to extracting active pharmaceutical ingredients (APIs) from various mineral resources. The firm's strategic objectives include manufacturing radiocontrast compounds derived from barium and iodine, in addition to developing pharmaceuticals that incorporate bromine. The company boasts complete ownership of three barium sulfate deposits in British Columbia, Canada, with two sites offering material suitable for the pharmaceutical barite industry. Furthermore, Voyageur holds stakes in a rich brine project in Utah, USA, which contains high concentrations of…

Open full interactive analysis & DCF →